<DOC>
	<DOCNO>NCT00294567</DOCNO>
	<brief_summary>In patient hypertension undergo elective PCI , effect long-term administration Calblock ( azelnidipine ) plaque volume determine quantitatively 3D-IVUS compare amlodipine besilate ( Norvasc Amlodin ) .</brief_summary>
	<brief_title>Azelnidipine Anti-Coronary Atherosclerotic Trial Hypertensive Patients Serial Volumetric IVUS Analysis ( ALPS-J )</brief_title>
	<detailed_description>Clinical study demonstrate calcium antagonist reduce cardiovascular event patient coronary artery disease . Recently , suppression development coronary atherosclerotic plaque calcium antagonist report one mechanism involve . Thus , calcium antagonist promise strategy prevent progression coronary atherosclerosis . Various calcium antagonist clinically available present drug may differ respect anti-atherosclerotic effect . Consequently , plan perform ALPS-J study compare effect two long-acting calcium antagonist , azelnidipine amlodipine , plaque quantitatively IVUS . In study , azelnidipine ( 16 mg/day ) amlodipine besilate ( 5 mg/day ) administer patient hypertension 48 week elective PCI . The plaque volume measure patient IVUS time PCI 48 week PCI . Percent change plaque volume baseline value use primary endpoint evaluation efficacy . We plan enroll 100 patient group total 200 patient .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>Age : Between 20 79 year ( time give informed consent ) . Sex : Either sex . Admission status : Outpatients . Patients require treatment hypertension accord JSH 2004 hypertension therapy guideline begin study Patients use calcium antagonist least 4 week begin study . Patients schedule undergo elective PCI . Patients acute coronary syndrome ( ACS ) . Patients experience Qwave myocardial infarction within 4 week begin study . Patients renal dysfunction ( serum creatinine &gt; 2.0 mg/dL ) . Patients PCI unsuccessful . Patients cardiogenic shock . Patients moderate severe congestive heart failure . Patients 50 % stenosis main trunk leave coronary artery . Patients problem investigator considers unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>PCI</keyword>
	<keyword>Calcium Channel Blockers</keyword>
	<keyword>IVUS</keyword>
	<keyword>Plaque</keyword>
</DOC>